Animas Corporation has announced emFood and Drug Administration (FDA)/em approval of the Animas Vibe insulin pump and Continuous Glucose Monitoring (CGM) system for the management of insulin-requiring diabetes in adults ages 18 and older. As the first and only integrated system featuring Dexcom G4 PLATINUM sensing technology with proven accuracy, Animas Vibe allows patients to view glucose data and administer insulin right from the pump; simplifying and ...
Read More
You have just read an article categorized health
titled FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System.
Written by:
editor -
Wednesday, December 3, 2014
There are currently no comments for "FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System"
Post a Comment